Vir Biotechnology, Inc. financial data

Symbol
VIR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1800 Owens Street, Suite 900, San Francisco, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.09K % +80.2%
Debt-to-equity 32.3 % -21%
Return On Equity -30.9 % -136%
Return On Assets -26 % -158%
Operating Margin -716 % -1018%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 137M shares +1.78%
Common Stock, Shares, Outstanding 137M shares +1.76%
Entity Public Float 1.8B USD -10%
Common Stock, Value, Issued 14K USD +7.69%
Weighted Average Number of Shares Outstanding, Basic 136M shares +1.62%
Weighted Average Number of Shares Outstanding, Diluted 136M shares +1.62%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 78.9M USD -83.9%
Cost of Revenue 947K USD -96.9%
Research and Development Expense 469M USD -21.2%
Costs and Expenses 643M USD -20.1%
Operating Income (Loss) -564M USD -79.7%
Nonoperating Income (Expense) 72.2M USD +83.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -492M USD -79.2%
Income Tax Expense (Benefit) -9.23M USD -102%
Net Income (Loss) Attributable to Parent -483M USD -84.4%
Earnings Per Share, Basic -3.58 USD/shares -81.7%
Earnings Per Share, Diluted -3.58 USD/shares -83.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 297M USD -55.5%
Marketable Securities, Current 850M USD -27.2%
Cash, Cash Equivalents, and Short-term Investments 1.43B USD -24.7%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 1M USD -92.3%
Assets, Current 1.21B USD -38.1%
Property, Plant and Equipment, Net 66.1M USD -36.6%
Operating Lease, Right-of-Use Asset 62.3M USD -16.9%
Intangible Assets, Net (Excluding Goodwill) 18.9M USD -26.1%
Goodwill 16.9M USD 0%
Assets 1.67B USD -25.6%
Accounts Payable, Current 4.39M USD -64.5%
Liabilities, Current 96.4M USD -57.3%
Deferred Income Tax Liabilities, Net 3.25M USD -82.4%
Operating Lease, Liability, Noncurrent 95M USD -19.4%
Other Liabilities, Noncurrent 13.9M USD +14.6%
Liabilities 236M USD -45.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.88M USD +0.83%
Retained Earnings (Accumulated Deficit) -441M USD -1162%
Stockholders' Equity Attributable to Parent 1.97B USD -1.51%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.43B USD -20.8%
Liabilities and Equity 1.67B USD -25.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -109M USD +13%
Net Cash Provided by (Used in) Financing Activities 152K USD -93.5%
Net Cash Provided by (Used in) Investing Activities 28.4M USD -71%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 137M shares +1.76%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -80.8M USD -219%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 317M USD -53.8%
Deferred Tax Assets, Valuation Allowance 357M USD +74.4%
Deferred Tax Assets, Gross 250M USD +158%
Operating Lease, Liability 125M USD -2.68%
Depreciation 4.2M USD -8.7%
Payments to Acquire Property, Plant, and Equipment 1.87M USD -72.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -483M USD -87.7%
Lessee, Operating Lease, Liability, to be Paid 156M USD -10.6%
Property, Plant and Equipment, Gross 99M USD -23.8%
Operating Lease, Liability, Current 19.5M USD +44%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.5M USD -11.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 18.8M USD -3.35%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 31.9M USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.9M USD +3.88%
Deferred Tax Assets, Operating Loss Carryforwards 138M USD +835%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 14.4M USD +19%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.1M USD +2.19%
Additional Paid in Capital 1.88B USD +6.01%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 133K USD 0%
Depreciation, Depletion and Amortization 17.8M USD +70%
Share-based Payment Arrangement, Expense 101M USD -4.39%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%